Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Form 40-APP/A CANTOR FITZGERALD SUSTAI
-
Cantor Fitzgerald Upgrades iBio, Inc. (IBIO) to Neutral
-
BTIG Fixed Income Continues Expansion with Several Key Hires
-
MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference
-
Pipeline Therapeutics Announces Participation in Upcoming Investor Conferences
-
EF Hutton Expands Healthcare Investment Banking Division with Addition of Senior Leadership
-
EF Hutton Expands Healthcare Investment Banking Division with Addition of Senior Leadership
-
Field Trip Health & Wellness to Participate in the Cantor Fitzgerald Symposium on Mental Health Clinics on October 11th
-
atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day
-
atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day
-
Cantor Fitzgerald Starts Irwin Naturals (IWINF) at Overweight
-
Form 8-K Cantor Fitzgerald Income For: Sep 30
-
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) CEO to Participate at Cantor Neurology & Psychiatry Conference
-
Vistagen to Participate at Cantor Neurology & Psychiatry Conference
-
NeuroSense CEO to be Panelist at Cantor Neurology and Psychiatry Conference
-
BioVie to Participate in Cantor Fitzgerald’s Neurology & Psychiatry Conference
-
Cognition Therapeutics to Participate in the 2022 Cantor Fitzgerald Neurology & Psychiatry Conference
-
Wellbeing Digital to Participate in the Cantor Fitzgerald Symposium on Mental Health Clinics
-
Cognition Therapeutics to Participate in the 2022 Cantor Fitzgerald Neurology & Psychiatry Conference
-
Zynerba Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
-
Zynerba Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
-
UPDATE: Cantor Fitzgerald Starts MSP Recovery, Inc. (MSPR) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Cerevel Therapeutics (CERE) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Cognition Therapeutics (CGTX) at Overweight
-
Tims China Completes Business Combination with Silver Crest Acquisition Corporation
-
Tims China Completes Business Combination with Silver Crest Acquisition Corporation
-
Analysts Discuss Implications for Eli Lilly (LLY) After Biogen's Big Win
-
UPDATE: Cantor Starts Enovix Corporation (ENVX) at Overweight (correction)
-
Mind Medicine (MNMD) Prices 7.06M Share Offering at $4.25/sh
-
MindMed Announces Pricing of Public Offering of Common Shares and Warrants
-
Today's Most Important Initiations
-
Mind Medicine (MNMD) Announces Proposed Stock Offering, Size not Disclosed
-
MindMed Announces Proposed Public Offering of Common Shares
-
SEC Charges 16 Wall Street Firms with Widespread Recordkeeping Failures
-
Form SC 13G Hennessy Capital Investm Filed by: CANTOR FITZGERALD SECURITIES
-
SEC Charges 16 Wall Street Firms with Widespread Recordkeeping Failures
-
Twitter, JetBlue, Lucid Group Rise Premarket; Avidity, Ferguson Fall
-
Cantor Fitzgerald Initiates Lucid Group (LCID) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Lucid Group Inc. (LCID) at Overweight
-
Cantor Fitzgerald Keeps $15 PT on Roivant Sciences (ROIV), 'Keep It Top Of Mind, Highly Anticipated Phase 3 AD Data Coming 1H23'
-
NioCorp to Combine with Nasdaq-Listed GXII (GXII) to Access Additional Capital for the Elk Creek Critical Minerals Project
-
Aravive to Participate in the Cantor Fitzgerald Oncology & HemOnc Conference
-
HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference
-
NioCorp to Combine with Nasdaq-Listed GXII to Access Additional Capital for the Elk Creek Critical Minerals Project
-
Actinium to Present at the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference
-
Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) Is ‘One to Watch’
-
Jasper Therapeutics to Present at Upcoming Conferences
-
Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences
-
PDS Biotech to Participate at Cantor Fitzgerald’s Oncology & HemOnc Conference
-
Form SC 13G PORTAGE FINTECH ACQUISIT Filed by: CANTOR FITZGERALD SECURITIES


